Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03592433 · ClinicalTrials.gov registry record · NA
Improving Cancer Patients' Insurance Choices
A NA study of Cancer and Health Literacy, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 263
- Enrollment target
- 1
- Study location
NCT03592433: Completed NA study of Cancer and Health Literacy, sponsored by Washington University School of Medicine.
NCT03592433 is a NA study of Cancer and Health Literacy that has completed, run by Washington University School of Medicine. The registered enrollment target is 263 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03592433, a NA study of Cancer and Health Literacy, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 263 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to find out if a decision aid (DA) created by investigators, I Can PIC, is effective in helping cancer patients make decisions about their health insurance. The investigators will evaluate I Can PIC compared to an attention control condition (existing website created by the American Cancer Society Cancer Action Network). The study hypothesis is that those randomly assigned to I Can PIC will have higher knowledge about health insurance terms and details, more certainty about the best health insurance plan for them, and more confidence in their health insurance decisions compared to those randomly assigned to the control condition.
Primary Outcome
The percent correct out of eight questions that were created by the research team based on information that is considered vital to making health insurance decisions.
Conditions Studied
Interventions
- BEHAVIORAL I Can PIC
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2018-06-27 |
| Est. Completion | 2019-02-28 |
| Phase | NA |
What the finished NCT03592433 record still lists
NCT03592433 is an interventional study that assigns participants to a tested intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower).
The record links to 5 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which I Can PIC is the first listed.
NCT03592433 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03592433 about?
NCT03592433 is a clinical study titled "Improving Cancer Patients' Insurance Choices". The goal of this research study is to find out if a decision aid (DA) created by investigators, I Can PIC, is effective in helping cancer patients make decisions about their health insurance. The investigators will evaluate I Can PIC compared to an attention control condition (existing website creat...
What is the current status of trial NCT03592433?
This trial is currently completed. It is a NA study. The enrollment target is 263 participants. The study started on 2018-06-27. Estimated completion is 2019-02-28.
What conditions does trial NCT03592433 study?
This clinical trial studies the following conditions: Cancer, Health Literacy, Health Insurance, Health Services Accessibility, Informed Decision Making.
What interventions are being tested in trial NCT03592433?
The interventions under investigation include: I Can PIC (BEHAVIORAL).
Who is sponsoring clinical trial NCT03592433?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03592433 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03592433's enrollment target sits among peer trials
263 199th of 615 higher than 417 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04067336 · 263 participants · Phase 1
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- NCT06234423 · 263 participants · Phase 1
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- NCT06724627 · 263 participants · NA
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI